Cargando…

Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population‐based analysis

BACKGROUND: The study was conducted to compare the clinicopathological characteristics, survival outcomes, and metastatic patterns between pulmonary large cell neuroendocrine carcinoma (LCNEC) and other non‐small cell lung cancer (ONSCLC), and to identify the prognostic factors of LCNEC. METHODS: Da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Qiao, Xu, Zihan, Chen, Xiewan, Zheng, Linpeng, Yu, Yongxin, Zhao, Xianlan, Chen, Mingjing, Luo, Bangyu, Wang, Jianmin, Sun, Jianguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449250/ https://www.ncbi.nlm.nih.gov/pubmed/30734490 http://dx.doi.org/10.1111/1759-7714.12993

Ejemplares similares

Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
por: Xu, Zihan, et al.
Publicado: (2019)

Survival Analysis and Prediction Model for Pulmonary Sarcomatoid Carcinoma Based on SEER Database
por: Chen, Mingjing, et al.
Publicado: (2021)

Immune Response on Optimal Timing and Fractionation Dose for Hypofractionated Radiotherapy in Non–Small-Cell Lung Cancer
por: Zhao, Xianlan, et al.
Publicado: (2022)

Clinicopathological characteristics and prognosis of pulmonary large cell neuroendocrine carcinoma aged ≥65 years
por: Cao, Ling, et al.
Publicado: (2019)

Clinicopathological characteristics and prognostic factors of pulmonary sarcomatoid carcinoma: a large population analysis
por: Gang, Jin, et al.
Publicado: (2021)

Hyperprogressive Disease In Cervical Small Cell Carcinoma Treated By Immune Checkpoint Inhibitor
por: Xu, Zihan, et al.
Publicado: (2019)

Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients
por: Yang, Qiao, et al.
Publicado: (2021)

Construction of nomograms for nasopharyngeal carcinoma containing primary tumor size and SEER stage
por: Yang, Guangrong, et al.
Publicado: (2020)

Clinicopathological characteristics, treatment and survival of pulmonary large cell neuroendocrine carcinoma: a SEER population-based study
por: Cao, Ling, et al.
Publicado: (2019)

Clinicopathological Characteristics and Prognostic Profiles of Breast Carcinoma with Neuroendocrine Features
por: Qiu, Yue, et al.
Publicado: (2023)

Large-cell neuroendocrine carcinoma of the kidney: Clinicopathologic features
por: Ratnagiri, Ranganath, et al.
Publicado: (2009)

Treatment outcome and prognostic analysis of advanced large cell neuroendocrine carcinoma of the lung
por: Xia, Lu, et al.
Publicado: (2022)

Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma
por: He, Yanqi, et al.
Publicado: (2019)

Risk factors and prognostic factors for pulmonary large cell neuroendocrine carcinoma with brain metastasis
por: Chen, Xiaoyun, et al.
Publicado: (2022)

Molecular Characterization and Prognostication of Large Cell Neuroendocrine Carcinoma and Large Cell Carcinoma
por: Chen, Ying, et al.
Publicado: (2022)

Pulmonary Large Cell Neuroendocrine Carcinoma
por: Yang, Lan, et al.
Publicado: (2022)

Urinary Large Cell Neuroendocrine Carcinoma: A Clinicopathologic Analysis of 22 Cases
por: Wang, Gang, et al.
Publicado: (2021)

Age‐specific clinicopathological characteristics and prognostic analysis of neuroendocrine carcinomas of the gallbladder
por: Zhang, Zhiwei, et al.
Publicado: (2021)

Concurrent EGFR‐TKI and Thoracic Radiotherapy as First‐Line Treatment for Stage IV Non‐Small Cell Lung Cancer Harboring EGFR Active Mutations
por: Zheng, LinPeng, et al.
Publicado: (2019)

Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas
por: Rieber, Juliane, et al.
Publicado: (2015)

Pulmonary large cell carcinoma with neuroendocrine morphology shows genetic similarity to large cell neuroendocrine carcinoma
por: Liang, Zuoyu, et al.
Publicado: (2022)

Pulmonary Combined Large Cell Neuroendocrine Carcinoma
por: Li, Meihui, et al.
Publicado: (2022)

CDX2 Expression and Prognostic Factors of Resectable Pulmonary Large Cell Neuroendocrine Carcinoma
por: Mori, Ryo, et al.
Publicado: (2020)

Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States
por: Xu, Zihan, et al.
Publicado: (2021)

Prostatic Metastasis of Pulmonary Large Cell Neuroendocrine Carcinoma
por: Shimizu, Kumi, et al.
Publicado: (2012)

Clinicopathological and genetic characteristics of pulmonary large cell carcinoma under 2015 WHO classification: a pilot study
por: Liu, Renwang, et al.
Publicado: (2017)

Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC)
por: Sun, Xujie, et al.
Publicado: (2022)

Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis
por: Zhang, Shuwen, et al.
Publicado: (2022)

A retrospective analysis of the clinicopathological characteristics of large cell carcinoma of the lung
por: LIANG, RUI, et al.
Publicado: (2015)

The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer
por: You, Qiai, et al.
Publicado: (2022)

Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy
por: Fasano, Morena, et al.
Publicado: (2015)

Neuroendocrine marker staining pattern categorization of small‐sized pulmonary large cell neuroendocrine carcinoma
por: Minami, Kazuhiro, et al.
Publicado: (2019)

Neuroendocrine Tumors of the Large Intestine: Clinicopathological Features and Predictive Factors of Lymph Node Metastasis
por: Kojima, Motohiro, et al.
Publicado: (2016)

Clinicopathological Characteristics and Prognostic Factors of Patients with Gastric Cancer Accompanying Neuroendocrine Differentiation (NEDGC)
por: Wang, Ya-Ping, et al.
Publicado: (2020)

Clinicopathological characteristics and prognostic factors of primary pulmonary lymphoma
por: He, Huayu, et al.
Publicado: (2021)

Pulmonary large-cell neuroendocrine carcinoma presenting as multiple cutaneous metastases
por: Mestre, Tiago, et al.
Publicado: (2015)

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
por: Derks, Jules L., et al.
Publicado: (2017)

Bronchial intraepithelial recurrence of a pulmonary large cell neuroendocrine carcinoma
por: Kojima, Hideaki, et al.
Publicado: (2020)

Pulmonary Large Cell Neuroendocrine Carcinoma Associated With Lambert-Eaton Syndrome
por: Hernandez-Arriaga, Pamela, et al.
Publicado: (2021)

Complete and durable response of pulmonary large‐cell neuroendocrine carcinoma to pembrolizumab
por: Kadota, Naoki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fqf2jn1cb5jfach06n9gep2qr7